HLB Life Science

Innovative therapies in oncology, immunology, and neuroscience

Seoul, South Korea · Founded 1998 · $5.0M raised

Headquarters
Seoul
Employees
11–50
Founded
1998
Business Model
B2B
Website
hlb-ls.com
Total Funding
$5.0M
Last Round
$5.0M Corporate RoundNov 2025
Rounds
1

About

HLB Life Science is a South Korean biopharmaceutical company focused on developing innovative therapies in oncology, immunology, and neuroscience. The company specializes in cell therapy and targeted cancer treatments, and also develops medical devices used in combination with pharmaceutical products. As part of the broader HLB Group, HLB Life Science conducts its own R&D and clinical programs while contributing to the group's pipeline of anti-cancer medications. The company is publicly listed on the Korean stock exchange and has pursued AI-powered drug development programs, including government-supported projects for AI oncology and medical cannabis research.

Summary

HLB Life Science is a Biotech company based in Seoul, South Korea, founded in 1998. It has raised $5.0M in total across 1 round, most recently a $5.0M Corporate Round round in Nov 2025.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Corporate RoundShare IssuanceNov 2025
$5.0M

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

HLB Life Science on Indexed.vc
<a href="https://indexed.vc/companies/hlb-life-science"><img src="https://indexed.vc/api/badge/company/hlb-life-science" alt="HLB Life Science on Indexed.vc" width="260" height="76" /></a>